Nanosuspension of a poorly soluble drug via microfluidization process
US9023886B2 · kind B2 · utility
1Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2010 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Oct 1, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/906
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compositions and methods for preparation and administration of an oral nanosuspension of a poorly soluble drug with improved bioavailability. The method is optimized through microfluidization process with water soluble polymeric excipients in the absence of surfactants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.